Therapeutic Solutions International, Inc. (TSOI)

Market Cap	589.22K
Revenue (ttm)	85.32K
Net Income (ttm)	-2.41M
Shares Out	5.89B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,078,149
Average Volume	15,396,152
Open	0.0002
Previous Close	0.0001
Day's Range	0.0001 - 0.0002
52-Week Range	0.0001 - 0.0011
Beta	1.24
RSI	36.37
Earnings Date	Mar 28, 2025

About TSOI

Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production. It also produces nutraceuti...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: TSOI

Financial Performance

In 2023, TSOI's revenue was $98,994, a decrease of -52.12% compared to the previous year's $206,767. Losses were -$2.17 million, -43.11% less than in 2022.